Merck (MRK) Reports In-Line Q4 EPS; offers guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $113.87 --0%
Revenue Growth %: +3.5%
Financial Fact:
Materials and production: 5.59B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +3.5%
Financial Fact:
Materials and production: 5.59B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q4 EPS of $2.04, in-line with the analyst estimate of $2.04. Revenue for the quarter came in at $16.4 billion versus the consensus estimate of $16.18 billion.
GUIDANCE:
Merck sees FY2026 EPS of $5.00-$5.15, versus the consensus of $5.63. Merck sees FY2026 revenue of $65.5-67 billion, versus the consensus of $67.576 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- SiteOne Landscape Supply (SITE) PT Lowered to $153 at Stifel
- Ledyard Financial Group names Charles Petersen as board chair
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
